Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Sichenzia Ross Ference LLP today announced that in 2021 it closed more than 80 capital markets transactions, ranging from less than $4 million to $200...
-
NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Sichenzia Ross Ference LLP today announced that it represented Relmada Therapeutics, Inc. (NASDAQ: RLMD), a late-stage biotechnology company addressing...
-
NEW YORK, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Sichenzia Ross Ference LLP, a leading full service law firm, announced today that Jorge Campos, Rajiv Radia, Mayank Pradhan, Ryan Flynn, Olivia Marin, and...
-
NEW YORK, July 13, 2021 (GLOBE NEWSWIRE) -- Sichenzia Ross Ference LLP, a leading securities and law firm, announced today the recent additions of three senior lawyers to its rapidly growing team...
-
NEW YORK, May 03, 2021 (GLOBE NEWSWIRE) -- On May 3, 2021, Sichenzia Ross Ference LLP (“SRF”), on behalf of its clients, CodeSmart Holdings, Inc. (“CodeSmart”) and Sharon Franey, won an appeal...
-
NEW YORK, April 06, 2021 (GLOBE NEWSWIRE) -- Sichenzia Ross Ference LLP, a leading securities and law firm, today announced that it represented Vuzix Corporation (NASDAQ: “VUZI”), a leading supplier...
-
NEW YORK, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Sichenzia Ross Ference LLP, a full service law firm with nationally recognized corporate, securities and litigation practices, announced today that it...
-
NEW YORK, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Sichenzia Ross Ference LLP (SRF) achieved voluntary dismissals in two lawsuits on behalf of its client, Vuzix Corporation (“Vuzix” or “Company”), a...
-
NEW YORK, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Sichenzia Ross Ference LLP announced today that it represented Relmada Therapeutics, Inc. (NASDAQ: RLMD), a clinical stage company developing depression...
-
NEW YORK and LOS ANGELES, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Sichenzia Ross Ference LLP (SRF), a full service law firm, announced today that it has added two new partners, Ovsanna Takvoryan and...